Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the MEKK1/MEK4/JNK signaling pathway in endotoxin-activated microglia
- 25 May 2002
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 293 (2) , 771-776
- https://doi.org/10.1016/s0006-291x(02)00283-8
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNγ synthesis by T cellsJournal of Neuroimmunology, 1999
- MAP kinase pathwaysProgress in Biophysics and Molecular Biology, 1999
- Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Polypeptide Inhibit Tumor Necrosis Factor α Transcriptional Activation by Regulating Nuclear Factor-kB and cAMP Response Element-binding Protein/c-JunJournal of Biological Chemistry, 1998
- Mitogen-activated protein kinases activated by lipopolysaccharide and β-amyloid in cultured rat microgliaNeuroReport, 1998
- In Vitro Properties of a High Affinity Selective Antagonist of the VIP1 ReceptorPeptides, 1997
- Molecules that protect: the defense of neurons and other cells.Journal of Clinical Investigation, 1996
- Identification of a Dual Specificity Kinase That Activates the Jun Kinases and p38-Mpk2Science, 1995
- JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domainPublished by Elsevier ,1994
- Phosphorylation of c-jun mediated by MAP kinasesNature, 1991
- Jun-B differs in its biological properties from, and is a negative regulator of, c-JunCell, 1989